πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8389502

Stabilized steroid composition and method for its preparation

Precision Dermatology, Inc. Β· Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8388643

Bioabsorbable polymeric implants and a method of using the same to create occlusions

The Regents of the University of California Β· Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8383102

Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradicat

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8378084

Fusion molecule based on novel TAA variant

The Regents of the University of California Β· Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8367734

Stable epinephrine suspension formulation with high inhalation delivery efficiency

Amphastar Pharmaceuticals, Inc. Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8365314

Coated elastomeric article and method for making a coated elastomeric article

Precision Components, Inc. Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8361982

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a

The Regents of the University of California Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8354390

Compositions and methods for inhibiting expression of a gene from the ebola virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349894

Compositions comprising an o/w emulsion containing conjugated linoleic acid

Aker Biomarine AS Β· Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349371

Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteina

China Medical University Β· Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8344126

Compositions and methods for inhibiting expression of XBP-1 gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8343737

Cell culture compositions capable of producing a VEGF-binding fusion polypeptide

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8334313

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the t

PTC THERAPEUTICS, INC. Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8334273

Compositions and methods for inhibiting expression of factor VII gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324368

GNAQ targeted dsRNA compositions and methods for inhibiting expression

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324181

Modulation of gene expression by oligomers targeted to chromosomal DNA

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318693

Compositions and methods for inhibiting expression of mutant EGFR gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318177

Viral chemokine-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8304397

Identification of a micro-RNA that activates expression of Ξ²-myosin heavy chain

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298532

Fusion polypeptides capable of activating receptors

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293707

Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288525

Compositions and methods for inhibiting expression of CD45 gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8283461

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

Benitec, Inc. Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8283308

Copolymer-stabilized emulsions

The Regents of the University of California Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted